Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
Contributeurs/tricesSmolen, Josef S; Schoels, Monika M; Nishimoto, Norihiro; Breedveld, Ferdinand C; Burmester, Gerd R; Dougados, Maxime; Emery, Paul; Ferraccioli, Gianfranco; Gabay, Cem; Gibofsky, Allan; Gomez-Reino, Juan Jesus; Jones, Graeme; Kvien, Tore K; Murakami, Miho; Betteridge, Neil; Bingham, Clifton O (3rd); Bykerk, Vivian; Choy, Ernest H; Combe, Bernard; Cutolo, Maurizio; Graninger, Winfried; Lanas, Angel; Martin-Mola, Emilio; Montecucco, Carlomaurizio; Ostergaard, Mikkel; Pavelka, Karel; Rubbert-Roth, Andrea; Sattar, Naveed; Scholte-Voshaar, Marieke; Tanaka, Yoshiya; Trauner, Michael; Valentini, Gabriele; Winthrop, Kevin L; de Wit, Maarten; van der Heijde, Désirée
Publié dansAnnals of the rheumatic diseases, vol. 72, no. 4, p. 482-492
Date de publication2013
Résumé
Mots-clés
- Antibodies, Monoclonal, Humanized/administration & dosage/adverse effects
- Antirheumatic Agents/administration & dosage/adverse effects
- Arthritis, Rheumatoid/drug therapy/immunology
- Drug Monitoring/methods
- Humans
- Inflammation/drug therapy/immunology
- Interleukin-6/antagonists & inhibitors
- Receptors, Interleukin-6/antagonists & inhibitors
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
SMOLEN, Josef S et al. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. In: Annals of the rheumatic diseases, 2013, vol. 72, n° 4, p. 482–492. doi: 10.1136/annrheumdis-2012-202469
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:45809
- DOI : 10.1136/annrheumdis-2012-202469
- PMID : 23172750
ISSN du journal0003-4967